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Hepatitis C virus (HCV) is well known etiological agent for 
causing chronic hepatitis, liver cirrhosis and hepatocellular 
carcinoma in developing as well as developed countries. 
An estimated 170 million people are chronically infected 
with HCV and 3–4 million people are newly infected 
each year[1]. The World Health Organization estimates 
that approximately 3% of the world population has been 
infected with HCV.
HCV infections are serious public health concern in 
Pakistan. The first description of HCV in Pakistan was 
in 1992 and since then there is no proper review[2]. With 
approximately 6% of the population being affected by it 
(approximately 10 million)[3], it is becoming a Herculean 
challenge. With the current disease burden, Pakistan has 
left behind all the major developed countries like Japan, 
USA and Europe[4].
The annual incidence of HCV in the industrialized nations 
has fallen in recent years, primarily because of effective 
blood screening efforts and increased education on the 
dangers of needle sharing. Contrary to that the burden 
of HCV related chronic liver disease (CLD) in Pakistan 
has increased. Studies from the past showed that of all 
patients presenting with CLD, 16.6% were anti-HCV 
antibody positive but more recent data shows nearly 
60–70% patients with CLD tend to be positive. Medical 
literature had also reported that nearly 50% patients with 
hepatocellular carcinoma (HCC) in Pakistan are anti- HCV 
antibody positive. 
Past medical literature reports a highly variable seroprevalence 
of HCV from different studies in different population and 
the trend continues within the same province. The reason is 
primarily attributed to HCV being a blood-borne infection, 
spreads rather sporadically or in micro epidemics. The 
most predominant HCV genotype is genotype 3 (75-90%), 
followed by genotypes 1, 2, and 5 [5].
In Pakistan, several population groups have been described 
as being at increased risk of HCV infection. In several 
published studies, the proportion of patients with HCV 
infection who received injections is in the range of 16% to 
100%. High prevalence of HCV has been recorded among 
middle-aged (40-50 years) people[6]. Haemodialysis 
patients were also noted to be at high risk of HCV infection. 
High HCV prevalence (23.7% to 68.0%) has been noted in 
this group of patients, and particularly those on long-term 
haemodialysis[7].
There are about 1.5 million units of blood products 
transfused each year in Pakistan[8]. Data on the safety of 
this transfusion process is rare which may be due to the lack 
of system of reporting infectious or non-infectious adverse 
events. The risk of HCV transmission through blood 
transfusion in Pakistan is still unknown but is considered to 
be high due to a lack of appropriate screening of blood.
Also, number of studies have shown the relationship 
between therapeutic injections using non-sterile needles 
and the transmission of HCV [3]. There is an enormous 
dependence on parenteral therapy for treatment, both in the 
form of injections and infusion of drips, driven by cultural 
beliefs in the power of parenteral therapy[6]. The general 
population of Pakistan typically prefers to be treated 
by injection rather than oral medication. Thus, patient 
demands and financial incentives for doctors favor the use 
of injectable treatment in patient care. Another significant 
risk factor of HCV transmission which had previously been 
reported from different regions of Pakistan is daily face and 
armpit shaving at community barber shops. The delicate 
skin of the face and armpit are susceptible to micro trauma, 
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leading to possible exposure to HCV through a contaminated 
traditional long-handled razor[3, 9]. Additional risk factors 
that may be important modes of transmission include ear 
piercing and non-sterile surgical and dental practices of 
unqualified health care workers (quacks)[10].
The HCV epidemic in Pakistan continues to rise due to 
lack of education and awareness of the disease, shortage 
of medically qualified and scientifically trained health 
care workers and lack of health infrastructure.  The 
government of Pakistan had taken some steps in this area 
in the past, by announcing a national blood policy in 2003. 
In 2001–2002 Pakistan received a grant from the Global 
Alliance for Vaccines and Immunization (GAVI) that 
has enabled the introduction of Hepatitis B vaccination 
in routine Expanded Program on Immunization (EPI)
[11]. Vaccination for HBV as part of EPI was launched 
in a nationwide vaccination campaign in 2004[12]. 
Unfortunately, HCV infection is not a notifiable disease 
in Pakistan and there is no national data collection system 
for evaluation of routine risk factors.
In March 2009, government officials reported  the Senate 
that around 8,800,000 people in Pakistan are suffering from 
deadly hepatitis C while another 5,600,000 are affected by 
hepatitis B[13] and that availability of diagnostic facilities 
and awareness campaigns have un-earthed the hidden 
burden of the disease. The Prime Minister Programme for 
Prevention and Control of Hepatitis was launched in August 
2005 with a total cost of Rs 2.594 billion for a period of five 
years[12]. The number of patients with the disease since 
then has increased significantly as the government started 
to provide free treatment, though on a limited scale. When 
the programme was launched in 2005-06 the number of 
patients, most of them poor, who were registered and treated 
at government hospitals were 10,815 and 1,000 for hepatitis 
C and B respectively. For the year 2008-09 the figure is 
84,773 and 7,204 respectively for the two categories of 
the disease[13]. If we critically analyze the figures with 
the present disease burden, we confront with the harsh fact 
that the gap between people getting affected each year and 
getting treatment is too wide and only a small population 
is seeking care with yet uninvestigated numbers of actually 
getting rid of the disease. The picture gets even gloomier if 
we realize that this what government is reporting and the 
ground reality may be even worse. The increasing HCV 
epidemic is likely to progress to a considerable increase in 
disease burden over the coming years.
The pillars of HCV infection control are blood safety, the 
prevention of needle sharing among Intravenous Drug 
Users (IVD), the strict implementation of standardized 
preventive measures in healthcare settings, screening of at 
risk groups and treatment of chronic hepatitis with multiple 
drug therapy (pegylated interferon and ribavirin). Despite 
its public health importance, however, how surveillance 
systems for hepatitis C should be designed is still a matter 
of debate. Cross sectional surveys on at risk population 
or groups are essential to estimate the burden of HCV 
infection and to describe affected persons who will need 
to be targeted for screening and treatment. However, they 
reflect past transmission routes, provide no information on 
the current dynamics of HCV transmission and no data on 
people currently getting infected.
Although the world is now hearing about Hepatitis awareness 
specially after commencement of the Hepatitis awareness 
day On May 19th every year from 2008, numerous efforts 
are required to prevent this day from becoming an event of 
seminars, lectures and conferences and the rest of the year , 
we forget about the disease.
We are living unfortunately without HCV vaccine, because 
of the virus high mutation rate and substantial heterogeneity 
of the genome of HCV. Still it is largely treatable and HCV 
infection can be cured by the existing antiviral drugs in 
more than 50% of the patients[14]. So efforts should be 
made to save the waste of at least 50% of these needless 
lives. Hepatitis preventing measures should include a 
situational analysis and a realistic assessment of the blood 
requirement in the area, followed by recruitment and 
maintenance of voluntary, non-remunerated blood donors 
and standardization and regulation of appropriate blood 
screening procedures. IDUs are numerous in Pakistani 
society and though they have a disproportionately high 
burden of health problems, they have been inadequately 
studied. Disseminating adequate information about 
all aspects of HCV is essential in developing patient 
understanding of the disease. It appears such information 
can only be effectively and reliably disseminated through 
effective awareness strategies. We also propose that for 
health promotion action, programmes should be made to 
increase awareness and use of specially prepared video 
clips for the prevention of disease. Media is one of the 
instrumentalities which facilitates and gives a directional 
thrust to the efforts to cure the disease if not to treat it. If 
medicine can treat Hepatitis, media is capable to prevent 
it with an ultimate goal to cure it through its capabilities 
to impart education through entertainment. 
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